Evidence map›Paper›PMID 35941331›Full record

ArticleDiscover oncology2022

miRNA-23b-5p affects the proliferation, migration and invasion of osteosarcoma by targeting TMEM127.

Dan Zu, Qi Dong, Jun Yao, Sunfang Chen, Bin Fang, Jun Ma, Bing Wu

Abstract read
In one paragraph

Article in Discover oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dan ZuCentral Laboratory, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China.
Qi DongDepartment of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China.
Jun YaoDepartment of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China.
Sunfang ChenDepartment of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China.
Bin FangDepartment of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China.
Jun MaDepartment of Neurology, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China. magofar@163.com.
Bing WuDepartment of Spine Surgery, The Central Hospital Affiliated to Shaoxing University, Shaoxing, 312030, China. wubing@usx.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteosarcoma (OS) has become one of the highest mortality cancers in the world due to its late diagnosis, rapid metastasis and rapid recurrence. MicroRNAs can regulate a variety of signaling pathwas involved in cancer development, such as cell proliferation, apoptosis and migration.

objectiveIn this study, we studied the biological effects and molecular regulation of mir-23b-5p on human osteosarcoma cells.

methodsThe proliferation of mir-23b-5p in osteosarcoma was measured by CCK8 method and EDU method. In addition, the target population was screened through the database, and the luciferase reporter gene was used to determine the association between miRNA and target gene TMEM127. We verified this result by Western blot.

resultsWe found that mir-23b-5p promotes the progression of osteosarcoma by regulating TMEM127.

conclusionsThe results of this study show that mir-23b-5p affects the proliferation, metastasis and invasion of OS by targeting TMEM127.

Indexed as

InvasionMigrationmiR-23b-5pOsteosarcomaProliferation

Identifiers

PMID35941331
PMCPMC9360392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.